Estrogen regulates Hippo signaling via GPER in breast cancer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The G protein-coupled estrogen receptor (GPER) mediates both the genomic and nongenomic effects of estrogen and has been implicated in breast cancer development. Here, we compared GPER expression in cancerous tissue and adjacent normal tissue in patients with invasive ductal carcinoma (IDC) of the breast and determined that GPER is highly upregulated in cancerous cells. Additionally, our studies revealed that GPER stimulation activates yes-associated protein 1 (YAP) and transcriptional coactivator with a PDZ-binding domain (TAZ), 2 homologous transcription coactivators and key effectors of the Hippo tumor suppressor pathway, via the Gαq-11, PLCβ/PKC, and Rho/ROCK signaling pathways. TAZ was required for GPER-induced gene transcription, breast cancer cell proliferation and migration, and tumor growth. Moreover, TAZ expression positively correlated with GPER expression in human IDC specimens. Together, our results suggest that the Hippo/YAP/TAZ pathway is a key downstream signaling branch of GPER and plays a critical role in breast tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence suggests that dysregulation of the Hippo-YAP/TAZ pathway is a central resistance mechanism in various tumors to multiple targeted therapies, chemotherapies, hormonal therapies, and immunotherapies (23–27).”
From YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis (2024) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationElucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · cited 2×
“Rapid mobilization of intracellular calcium, which is widely observed upon GPER stimulation (4, 36), is a representative phenomenon of activation of phospholipase Cβ (PLCβ) signaling, which is directly controlled by the specific G protein Gαq/11 (5, 38).”
BackgroundThe Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Self-citationA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Self-citationIdentity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Research works printed but not linked: 1
- 10.1210/mend.14.10.0532 · DOI · Paper page
Cited by
Items 101–200 of 251
GPER Activation Inhibits Cancer Cell Mechanotransduction and Basement Membrane Invasion via RhoA
Rice, A. J., Cortés, E., Lachowski, D., Oertle, P., Matellan, C., Thorpe, S. D., Ghose, R., Wang, H., Lee, D. A., Plodinec, M., et al. (2020) · Cancers · doi:10.3390/cancers12020289 · Cited by 31
Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer
Zhao, X., Fu, J., Hu, B., Chen, L., Wang, J., Fang, J., Ge, C., Lin, H., Pan, K., Fu, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639111 · Cited by 31
Manjegowda, M. C., Gupta, P. S., & Limaye, A. M. (2017) · Gene · doi:10.1016/j.gene.2017.03.006 · Cited by 30
GPER: An Estrogen Receptor Key in Metastasis and Tumoral Microenvironments
Tirado-Garibay, A. C., Falcón-Ruiz, E. A., Ochoa‐Zarzosa, A., & López-Meza, J. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914993 · Cited by 29
Meng, R., Qin, Q., Xiong, Y., Wang, Y., Zheng, J., Zhao, Y., Tao, T., Wang, Q., Liu, H., Wang, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10713 · Cited by 29
Self-citationTargeting Hippo signaling pathway by phytochemicals in cancer therapy.
Moloudizargari, M., Asghari, M., Nabavi, S., Gulei, D., Berindan-Neagoe, I., Bishayee, A., & Nabavi, S. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.005 · Cited by 27
Arakaki, A. K. S., Pan, W., Wedegaertner, H., Roca-Mercado, I., Chinn, L., Gujral, T. S., & Trejo, J. (2021) · Journal of Cell Science · doi:10.1242/jcs.254888 · Cited by 29
Hu, L., Peng, T., Huang, J., Su, T., Luo, R., Zheng, Y., Zhong, Z., Yu, P., Nie, K., & Zheng, L. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.10.007 · Cited by 29
Liu, Y., Zhang, Q., Wu, J., Zhang, H., Li, X., Zheng, Z., Luo, M., Li, L., Xiang, Y., Yang, F., et al. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s278564 · Cited by 29
Jacenik, D., & Krajewska, W. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00390 · Cited by 28
Amanda, B., Pragasta, R., Cakrasana, H., Mustika, A., Faizah, Z., & Oceandy, D. (2024) · Cells · doi:10.3390/cells13221868 · Cited by 28
Estrogenic hormones receptors in Alzheimer’s disease
Tecalco-Cruz, Á. C., Zepeda–Cervantes, J., & Ortega-Domínguez, B. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06792-1 · Cited by 27
Bicarbonate signalling via G protein-coupled receptor regulates ischaemia-reperfusion injury
Jo‐Watanabe, A., Inaba, T., Osada, T., Hashimoto, R., Nishizawa, T., Okuno, T., Ihara, S., Touhara, K., Hattori, N., Oh‐hora, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45579-3 · Cited by 27
Wang, X., Xia, X., Xu, E., Yang, Z., Shen, X., Du, S., Chen, X., Lu, X., Jin, W., & Guan, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592919 · Cited by 27
Soyama, H., Nishio, M., Otani, J., Sakuma, T., Takao, S., Hara, S., Masuda, T., Mimori, K., Toyokuni, S., Lydon, J. P., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123134119 · Cited by 26
Phytoestrogens, novel dietary supplements for breast cancer
Huang, S., Qi, B., Yang, L., Wang, X., Huang, J., Zhao, Y., Hu, Y., & Xiao, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114341 · Cited by 26
Hippo vs. Crab: tissue‐specific functions of the mammalian Hippo pathway
Nishio, M., Maehama, T., Goto, H., Nakatani, K., Kato, W., Omori, H., Miyachi, Y., Togashi, H., Shimono, Y., & Suzuki, A. (2017) · Genes to Cells · doi:10.1111/gtc.12461 · Cited by 26
Neto, C. P. D. O., Brito, H. O., da Costa, R. M. G., & Brito, L. M. O. (2021) · Anticancer Research · doi:10.21873/anticanres.15162 · Cited by 26
Chen, J., Wang, X., Qian, H., Yang, H., Fogo, A. B., & Harris, R. C. (2024) · Kidney International · doi:10.1016/j.kint.2024.01.038 · Cited by 25
Hou, L., Xie, S., Li, G., Xiong, B., Yanchun, G., Zhao, X., Hu, J., Deng, S., & Jiang, J. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13042 · Cited by 24
Shining the light on mesenchymal stem cell-derived exosomes in breast cancer
Al‐Awsi, G. R. L., Alsaikhan, F., Margiana, R., Ahmad, I., Patra, I., Najm, M. A. A., Yasin, G., Rasulova, I., Hammid, A. T., Kzar, H. H., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03245-3 · Cited by 24
X talk : a path-based approach for identifying crosstalk between signaling pathways
Tegge, A. N., Sharp, N., & Murali, T. M. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv549 · Cited by 24
Saha, T., & Lukong, K. E. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1513225 · Cited by 23
Papageorgiou, K., Mastora, E., Zikopoulos, A., Grigoriou, M. E., Georgiou, I. A., & Michaelidis, T. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.702446 · Cited by 23
Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
Lin, K. C., Park, H. W., & Guan, K. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050202 · Cited by 22
Self-citationAliagan, A. I., Madungwe, N. B., Tombo, N., Feng, Y., & Bopassa, J. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.579161 · Cited by 21
Martínez-Bernabé, T., Sastre‐Serra, J., Ciobu, N., Oliver, J., Pons, D. G., & Roca, P. (2021) · Antioxidants · doi:10.3390/antiox10091371 · Cited by 22
Estrogen dysregulation, intraocular pressure, and glaucoma risk
Youngblood, H. A., Schoenlein, P. V., Pasquale, L. R., Stamer, W. D., & Liu, Y. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109725 · Cited by 21
Ercolani, C., Benedetto, A. D., Terrenato, I., Pizzuti, L., Lauro, L. D., Sergi, D., Sperati, F., Buglioni, S., Ramieri, M. T., Mentuccia, L., et al. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1312230 · Cited by 20
Hippo signaling pathway: A comprehensive gene expression profile analysis in breast cancer
Yousefi, H., Delavar, M. R., Piroozian, F., Baghi, M., Nguyen, K., Cheng, T., Vittori, C., Worthylake, D. K., & Alahari, S. K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113144 · Cited by 20
Zhao, Z., Niu, S., Chen, J., Zhang, H., Liang, L., Xu, K., Dong, C., Su, C., Yan, T., Zhang, Y., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.12.003 · Cited by 19
Duan, L., Liu, J., Yu, C., Fan, J., Li, T., Yang, J., Zheng, Y., Liu, F., He, Z.-T., Yuan, H., et al. (2020) · PubMed Central · Cited by 19
Self-citationZhang, T., Guo, S., Zhou, H., Wu, Z., Liu, J., Qiu, C., & Deng, G. (2021) · Cell Proliferation · doi:10.1111/cpr.12976 · Cited by 19
STK3 Suppresses Ovarian Cancer Progression by Activating NF‐ κ B Signaling to Recruit CD8 + T‐Cells
Wang, X., Wang, F., Zhang, Z., Yang, X., & Zhang, R. (2020) · Journal of Immunology Research · doi:10.1155/2020/7263602 · Cited by 19
The hippo pathway: a molecular bridge between environmental cues and pace of life
Ahi, E. P., Panda, B., & Primmer, C. R. (2025) · BMC Ecology and Evolution · doi:10.1186/s12862-025-02378-8 · Cited by 18
An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis
Yan, H., Zhang, J.-L., Leung, K. T., Lo, K. W., Yu, J. Q., To, K., & Kang, W. (2023) · Cancers · doi:10.3390/cancers15030736 · Cited by 18
Deng, Z., Xie, H., Cheng, W., Zhang, M., Liu, J., Huo, Y., Liao, Y., & Cheng, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15485 · Cited by 18
Targeting YAP/TAZ–TEAD and their protein-protein interaction for precision cancer therapy
Chen, F., Su, J., Liu, Y., Zhang, Z., Li, S., Yuan, Y., & Lai, J. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118330 · Cited by 18
Two faces of Hippo: activate or suppress the Hippo pathway in cancer
Cao, J., & Huang, W. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000559 · Cited by 17
Ye, S., Xu, Y., Wang, L., Zhou, K., He, J., Lu, J., Huang, Q., Sun, P., & Wang, T. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s265372 · Cited by 17
Liu, Z., Li, S., Chen, S., Sheng, J., Li, Z., Lv, T., Yu, W., Fan, Y., Wang, J., Liu, W., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109125 · Cited by 16
Poly(rC)-Binding Protein 2 Regulates Hippo Signaling To Control Growth in Breast Epithelial Cells
Li, F., Zumbrennen‐Bullough, K. B., Vashisht, A. A., Wohlschlegel, J. A., & Philpott, C. C. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00104-16 · Cited by 16
Self-citationMuhammad, A. I., Forcados, G. E., Yusuf, A. P., Abubakar, M. B., Sadiq, I. Z., Elhussin, I. A., Siddique, M. A. T., Aminu, S., Suleiman, R. B., Abubakar, Y. S., et al. (2022) · Molecules · doi:10.3390/molecules27248943 · Cited by 15
Melucci, E., Casini, B., Ronchetti, L., Pizzuti, L., Sperati, F., Pallocca, M., Nicola, F. D., Goeman, F., Gallo, E., Amoreo, C. A., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1385-y · Cited by 15
Li, Y., Yan, L., Wang, A., Jiang, L., Xu, Q., & Wang, B. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24694 · Cited by 15
Bubb, M., Beyer, A.-S. L., Dasgupta, P., Kaemmerer, D., Sänger, J., Evert, K., Wirtz, R. M., Schulz, S., & Lupp, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095191 · Cited by 14
Saranya, R., Rajkumar, C., Mohideen, K., Adtani, P., Subramani, V. N., & Balasubramaniam, M. (2022) · Cureus · doi:10.7759/cureus.25384 · Cited by 14
Cunningham, R., Jia, S., Purohit, K. P., Salem, O., Hui, N. S., Lin, Y., Carragher, N. O., & Hansen, C. G. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1190 · Cited by 13
Sun, X., Zeng, C., Wang, F., Zhang, Z., Yang, F., Liu, Z., Li, K., & Zhang, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113402 · Cited by 13
Zhang, K., Li, J., & Li, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6486109 · Cited by 13
Bajpai, A. K., Gu, Q., Jiao, Y., Starlard‐Davenport, A., Gu, W., Quarles, L. D., Xiao, Z., & Lu, L. (2023) · Genomics · doi:10.1016/j.ygeno.2023.110769 · Cited by 12
Role of G Protein-Coupled Estrogen Receptor in Digestive System Carcinomas: A Minireview
Qiu, Y., Xiong, J., & Yu, T. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s291896 · Cited by 12
Liu, X., Kim, J. H., Li, X., & Liu, R. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124732 · Cited by 12
Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer
Chen, J., Wan, R., Li, Q., Rao, Z., Wang, Y., Zhang, L., & Teichmann, A. T. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01999-5 · Cited by 12
Control of myeloid cell density in barrier tissues
Lohrmann, F., Forde, A. J., Merck, P., & Henneke, P. (2020) · FEBS Journal · doi:10.1111/febs.15436 · Cited by 11
Lin, X., Chen, W., Wei, F., Zhou, B. P., Hung, M., & Xie, X. (2017) · International Journal of Cancer · doi:10.1002/ijc.30658 · Cited by 11
Guan, Y., Gong, Z., Xiao, T., & Li, Z. (2018) · Europe PMC (PubMed Central) · Cited by 11
An, S., Gao, X., Wang, Z., Liang, Y., Wang, S., Xiao, S., Xia, J.-T., You, P., Wang, F., & Zhang, G. (2020) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2020.106328 · Cited by 11
Self-citationTeper, Y., Ye, L., Waldron, R. T., Lugea, A., Sun, X., Sinnett-Smith, J., Hines, O. J., Pandol, S. J., Rozengurt, E., & Eibl, G. (2023) · Scientific Reports · doi:10.1038/s41598-023-43498-9 · Cited by 10
“In a similar context, estrogens have been reported to regulate Hippo signaling via G-protein coupled estrogen receptor (GPER) in breast cancer leading to activation of YAP and TAZ 45 .”
The emerging role of estrogen's non-nuclear signaling in the cardiovascular disease
Tokiwa, H., Ueda, K., & Takimoto, E. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1127340 · Cited by 10
Segura‐Bautista, D., Olivares, A., Casas-González, P., Bonilla, E., Salazar, Z., & P�rez‐Solis, M. (2020) · Oncology Reports · doi:10.3892/or.2020.7540 · Cited by 10
Wang, L., Geng, M., Wei, L., Wang, S., Wang, W., & Liu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1742246 · Cited by 9
Self-citationMárton, É., Varga, A. I., Penyige, A., Birkó, Z., Balogh, I., Nagy, B., & Szilágyi, M. (2023) · Toxins · doi:10.3390/toxins15020140 · Cited by 9
Mechanosensitive Steroid Hormone Signaling and Cell Fate
Northey, J. J., & Weaver, V. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac085 · Cited by 9
Ai, L., Yuan, R., Chen, X., Liu, Y., Liu, W., Zhu, J., Zhang, Z., Yan, J., Chen, C., Lin, S., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12757 · Cited by 9
YAP1 inhibits ovarian endometriosis stromal cell invasion through ESR2
Zeng, C., Wu, P., Dong, Z.-T., Li, X., Zhou, Y., & Xue, Q. (2020) · Reproduction · doi:10.1530/rep-19-0565 · Cited by 9
Ye, C., Hu, Y., Wang, J., Liu, D., & Du, J. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108773 · Cited by 9
YAP1/TAZ activity maintains vascular integrity and organismal survival
Uemura, S., Yamashita, M., Aoyama, K., Yokomizo‐Nakano, T., Oshima, M., Nishio, M., Masuko, M., Takizawa, J., Sone, H., Yamada, Y., et al. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.050 · Cited by 8
GPER-1 and sex-hormone levels in patients with otosclerosis
Erdem, D., Eliçora, S. Ş., Güven, B., & Dinç, A. E. (2020) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2020.102442 · Cited by 8
He, Y., Yang, K., Liu, J., Shi, D., Zhang, Z., Yang, J., Chen, M., & Zhao, P. (2023) · Disease Markers · doi:10.1155/2023/8371623 · Cited by 8
Lappano, R., & Maggiolini, M. (2023) · Cells · doi:10.3390/cells12040626 · Cited by 8
Peng, S., Tang, B., Xie, S., Zhang, Z., Fan, J., Wei, Z., & Song, C. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28118 · Cited by 8
Awasthi, B. P., Chaudhary, P., Lim, D., Yadav, K., Lee, I., Banskota, S., Chaudhary, C. L., Karmacharya, U., Lee, J., Im, S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02458 · Cited by 7
Yang, T., Qiu, Z. D., Shen, J., He, Y., Yin, L., Chen, L., Yuan, J., Liu, J., Wang, T., Jiang, Z., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.03.003 · Cited by 7
Guo, H., Yu, H., Feng, Y., Cheng, W., Li, Y., & Wang, Y. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20055-x · Cited by 7
Interaction of Bisphenol A with G Protein: Coupled Receptors - New Paradigms in Breast Cancer
Molina, L., Figueroa, C. D., & Ehrenfeld, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101204 · Cited by 7
Targeting the Hippo Pathway to Improve Response to Chemotherapy
Zhao, Y., & Yang, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813753-6.00008-1 · Cited by 6
Tran, T. T. T., Phung, T. M., Do, A. T. M., Ly, Q. T. M., & Nguyen, T. H. (2025) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog26813 · Cited by 6
Darbankhales, S., Mirfakhraie, R., Ghahremani, H., Asadolahi, M., Saket-Kisomi, K., Safakish, L., Darbeheshti, S., Ganjkhanlou, Z., Salami, S., & Sirati‐Sabet, M. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.11.3171 · Cited by 6
Yu, T., He, C., Zhang, H., Zhu, Y., Wang, A., Zeng, X., Huang, Y., Zhong, J., Wu, X., Shu, Y., et al. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101716 · Cited by 5
Huang, Z.-L., Xu, B., Li, T., Xu, Y., Huang, X., & Huang, X.-Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.878923 · Cited by 5
Wang, Y., Sun, Y., Zhao, W., Zhang, J., Wang, X., Hu, F., Han, Z., Wang, L., Liu, L., Liu, B., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101199 · Cited by 4
Self-citationLi, J., Ren, J., Zhang, W., Ren, A., Jiao, B., & Yang, W. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003605 · Cited by 4
Endocrine regulation of cancer stem cell compartments in breast tumors
Zheng, Y., & Karnoub, A. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111374 · Cited by 4
Ingavle, G. C., & Das, M. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00484 · Cited by 3
Wang, H., Menachem-Zidon, O. B., Pandey, A. K., Xiao, Y., Deng, N., Shi, X., Ruiz, A., Ye, Y., & Cai, H. (2025) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-025-00867-w · Cited by 3
Oyanagi, M., Konno, T., Nishida, S., Kohno, T., Kimura, I., Nakano, M., Ohwada, K., Kakuki, T., Obata, K., Kakiuchi, A., et al. (2026) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-025-09959-9 · Cited by 3
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
Schiavoni, G., Palmese, A., Scalera, S., Cipriani, L., Mascolo, D., Vici, P., Arcuri, T., Filomeno, L., Krasniqi, E., Blandino, G., et al. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70232 · Cited by 4
Lasagna, M., Enriquez, L., Mardirosian, M. N., Cardozo, R., Martín, G., Power, P. P., Núñez, M., & Cocca, C. (2025) · Environmental Research · doi:10.1016/j.envres.2025.123447 · Cited by 3
Li, Y., Xu, Y., & Lu, P. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s412155 · Cited by 3
Hwang, S., Kim, B., Kim, J., Suh, Y., Lee, J., Park, S., Lee, O., Lee, M. R., & Choi, Y. (2025) · Development & Reproduction · doi:10.12717/dr.2025.29.2.31 · Cited by 3
GPER agonist G-1 activates YAP to induce apoptosis in breast cancer cells
Fu, Z., Xin, X., Zhan, Y., Fan, X., Li, X., Chen, T., & Wang, X. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106693 · Cited by 2
More than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer
Molina, L., Torres, R. F., Spies, J., Meneses, S. S., Soto, M., Carrasco, J., Gálvez, J., Muñoz, D., Soto, J., & Arancibia, Y. (2026) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2026.1002377 · Cited by 2
Liu, P., Zeng, J., & Yang, G. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11356 · Cited by 2
Self-citationLv, H., Xu, X., Wu, Z., Lin, Y., Liu, Y., Liu, M., Xu, L., Wang, X., Sun, N., Abdel-Shafy, H., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139290 · Cited by 2
Hippo signaling pathway and mitochondrial dysfunction in Takotsubo syndrome
Miyamoto, S. (2023) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00080.2023 · Cited by 2
Tan, S., Huang, X., Li, J., Nepovimová, E., Valko, M., Wu, Q., & Kuča, K. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112208 · Cited by 1
Importance of GPER1, HO-1, HO-2 expression in the endometrium in patients with chronic endometritis
Lyzikova, Y. A., Zinovkin, D. A., & Воропаев, Е. В. (2021) · Health and Ecology Issues · doi:10.51523/2708-6011.2021-18-3-21 · Cited by 1
Targeting YAP: mechanistic breakthroughs and therapeutic prospects in reversing organ fibrosis
Fu, K., Cao, M., Wang, Y., Luo, J., & Yuan, W. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05540-y · Cited by 1
Helou, M. E. (2017) · theses.fr (ABES) · doi:10.70675/0c7d676dz64a3z4641zb8cbzd99a75ef2126 · Cited by 1
Metadata
- Authors
- Zhou, X., Wang, S., Wang, Z., Feng, X., Liu, P., Lv, X.-B., Li, F., Yu, F.-X., Sun, Y., Yuan, H., Zhu, H., Xiong, Y., Lei, Q.-Y., & Guan, K.-L.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Zhou, Xin
- Wang, Shuyang
- Xiong, Yue
- Lei, Qun-Ying
- Guan, Kun-Liang
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2015-04-20
- Volume
- 125
- Issue
- 5
- Pages
- 2123-2135
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4463207
- OpenAlex
- W2008439293
- Cited by
- 232
- References
- 50
- Citations by year
- 2026: 19 · 2025: 14 · 2024: 14 · 2023: 20 · 2022: 22 · 2021: 25 · 2020: 32 · 2019: 17 · 2018: 21 · 2017: 27 · 2016: 15 · 2015: 4
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UNC Libraries
- Funders
- Shanghai Key Basic Research Program
- National Natural Science Foundation of China (81430057, 2012CB910101, 31271454, 81225016)
- Ministry of Science and Technology of the People's Republic of China (2012CB910101, 2011CB910601, 2015CB910401)
- Fudan University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- G protein-coupled estrogen receptor, Hippo signaling pathway, YAP, TAZ, breast cancer, invasive ductal carcinoma, Gαq/11, Rho/ROCK signaling, tumor growth, cell proliferation, cell migration
- MeSH terms
- Hippo Signaling Pathway, Serine-Threonine Kinase 3, YAP-Signaling Proteins, Hippo Kinases, Acyltransferases, Animals, Breast Neoplasms, Cell Division, Cell Movement, Cell Transformation, Neoplastic, Estrogens, Female, Humans, Mice, Inbred BALB C, Neoplasm Proteins, Neoplasms, Hormone-Dependent, Phosphoproteins, Phosphorylation, Protein Kinase C, Protein Processing, Post-Translational, Receptors, Estrogen, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Carcinoma, Ductal, Breast, Tumor Suppressor Proteins, RNA Interference, Receptors, G-Protein-Coupled, GTP-Binding Protein alpha Subunits, Gq-G11, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, rho-Associated Kinases, Phospholipase C beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.